SIDLEY AUSTIN LLP

Lobbying for KARYOPHARM THERAPEUTICS · Pharmaceutical manufacturer

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · Massachusetts · House · Senate · posted Apr 20, 2026

Lobbying activity 1

Health Issues

Rare disease policy, drug approval process

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem